Therefore, targeting miR-518d-5p, which induces the c-Jun-PUMA axis, represents a novel mechanism to induce apoptosis in hepatoma cells and enhance the response to sorafenib. This evidence concerns the gene BBC3 and hepatocellular carcinoma.